
Liquidity, historical trends, and peer comparisons.
According to Akso Health Group’s latest financial reports and current stock price. The company's current Current Ratio is 21.77. This represents a change of 86.86% compared to the average of 11.65 of the last 4 quarters.
The mean historical Current Ratio of Akso Health Group over the last ten years is 10.09. The current 21.77 Current Ratio has changed 115.62% with respect to the historical average. Over the past ten years (40 quarters), HX's Current Ratio was at its highest in in the December 2023 quarter at 39.52. The Current Ratio was at its lowest in in the June 2016 quarter at 0.
Average
10.09
Median
4.93
Minimum
1.24
Maximum
39.52
Discovering the peaks and valleys of Akso Health Group Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.14%
Maximum Annual Current Ratio = 39.52
Minimum Annual Increase = -64.07%
Minimum Annual Current Ratio = 1.24
| Year | Current Ratio | Change |
|---|---|---|
| 2026 | 21.77 | 53.29% |
| 2025 | 14.20 | -64.07% |
| 2024 | 39.52 | 2.14% |
| 2023 | 1.76 | 42.03% |
| 2022 | 1.24 | -40.68% |
| 2021 | 2.09 | -50.34% |
| 2020 | 4.21 | 14.43% |
| 2019 | 3.68 | -46.24% |
| 2018 | 6.84 | 21.09% |
| 2017 | 5.65 | 392.11% |
The current Current Ratio of Akso Health Group (HX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
25.16
5-year avg
15.70
10-year avg
10.09
Akso Health Group’s Current Ratio is greater than Eargo, Inc. (4.60), greater than Kronos Bio, Inc. (7.54), greater than Sigilon Therapeutics, Inc. (2.40), greater than Singular Genomics Systems, Inc. (10.51), greater than Bonk, Inc. (1.05), greater than AlloVir, Inc. (10.98), greater than Heat Biologics, Inc. (0.00), greater than AlerisLife Inc. (1.33), greater than NeueHealth, Inc. (0.61), greater than TCR2 Therapeutics Inc. (2.77),
| Company | Current Ratio | Market cap |
|---|---|---|
| 4.60 | $53.36M | |
| 7.54 | $53.65M | |
| 2.40 | $56.22M | |
| 10.51 | $50.77M | |
| 1.05 | $8.16M | |
| 10.98 | $49.48M | |
| 0.00 | $61.07M | |
| 1.33 | $44.18M | |
| 0.61 | $60.94M | |
| 2.77 | $58.11M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Akso Health Group using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Akso Health Group or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Akso Health Group's Current Ratio?
How is the Current Ratio calculated for Akso Health Group (HX)?
What is the highest Current Ratio for Akso Health Group (HX)?
What is the 3-year average Current Ratio for Akso Health Group (HX)?
What is the 5-year average Current Ratio for Akso Health Group (HX)?
How does the current Current Ratio for Akso Health Group (HX) compare to its historical average?